TrialInternational journal of clinical oncology2020

Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study.

Taro Iguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.